Zynex Inc.‘s filing for bankruptcy protection means stockholders can no longer pursue allegations board members and former executives hid a practice of overbilling insurers, those plaintiff-investors told a federal judge in Denver.
Standing to sue is extinguished while the medical device company’s bankruptcy estate has the authority to bring claims on Zynex’s behalf, the shareholders told the US District Court for the District of Colorado. The investors voluntarily dismissed their derivative lawsuit, being overseen by Judge
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.